Moreover, the present results revealed central carbon metabolism (CCM) disruption in PD and PPAR signaling inactivation in PD-RBD, linking metabolic dysfunction to neurodegeneration and highlighting CCM and PPAR signaling pathways as therapeutic targets. This evidence concerns the gene PPARA and Parkinson disease.